Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Evolent

Explore full profile

Value-based care platform optimizing specialty clinical performance

Arlington, United StatesFounded 2011Health Tech & Medtech
Valuation $1.19B Market cap · Aug/2026
Revenue $2.50B Latest reported FY
EBITDA $126M Latest reported FY

At a glance

Status
Listed
Founded
2011
Headquarters
Arlington, United States
Listing
IPO 2015
Sector
Health Tech & Medtech
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later5 investors entered at this stage

  • Oxeon
  • The Advisory Board Company
  • TPG
  • UPMC Enterprises
  • TPG Growth

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
9 countries with
team presence
🇺🇸 United States68.5%
🇮🇳 India29.3%
🇵🇭 Philippines1.7%
🇳🇵 Nepal0.1%
🏳️ Mauritius0.1%
Top 5 of 9 shown
Web traffic by country
26K monthly visits
across markets
🇺🇸 United States65%
🇮🇳 India18.1%
🇨🇦 Canada8.5%
🇬🇧 United Kingdom5.4%
🇵🇭 Philippines1.9%
Top 5 markets shown

Investments and acquisitions

Disclosed deals where Evolent was the backer or acquirer, 2017–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across Evolent's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Evolent's portfolio, mapped.

        Stage
        Period
        5 of 5 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Evolent on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Evolent on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles